Ligand · VHJ
VHJ · N-[(benzyloxy)carbonyl]-L-valyl-N-{(2S)-1-hydroxy-3-[(3R)-2-oxo-3,4-dihydro-2H-pyrrol-3-yl]propan-2-yl}-L-phenylalaninamide
VHJ, N-[(benzyloxy)carbonyl]-L-valyl-N-{(2S)-1-hydroxy-3-[(3R)-2-oxo-3,4-dihydro-2H-pyrrol-3-yl]propan-2-yl}-L-phenylalaninamide (C29 H38 N4 O6, 538.6 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every…
- Component
- VHJ
- Formula
- C29 H38 N4 O6
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
VHJ in 2 structures; the first of them:
- 7JQ1 · Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI4 · VHJ A401 · binds HIS41, MET49, TYR54, PHE140, LEU141, ASN142, GLY143, SER144 and 14 more
- 7JQ1 · Structure of the SARS-cov-2 main protease in complex with inhibitor MPI4 · VHJ A401 · binds HIS41, MET49, TYR54, PHE140, LEU141, ASN142, GLY143, SER144 and 14 more
Residues it binds most
HIS 2, GLN 2, LEU 2, MET 2, ALA 2, ARG 2, ASN 2, ASP 2, CYS 2, GLU 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.